Scientists at universities and pharmaceutical companies alike in the next several years may be working in a transformed research environment, one in which ideas may more quickly and cheaply be ...

China-based companies, others with facilities or collaborative ventures in China, and academic groups all committed to advancing RNA-interference (RNAi) research and therapeutic drug development were ...